Vaccine Market Outlook, Key Trends and Product Pipeline and in the US

CHALLENGE

Our client, a European private equity, sought to gain a detailed understanding of the market for private-paid vaccines in the United States, excluding COVID-19 vaccines. The focus was on identifying key trends in vaccination usage, such as whether there has been an increase in vaccine uptake post-COVID, the types of vaccines that people are paying for out-of-pocket (e.g., travel vaccines, influenza vaccines), and the vaccines expected to emerge or gain popularity in the coming years. The goal was to explore the driving factors behind market growth, current market dynamics, and the future outlook of vaccine trends.

OUR APPROACH

BTHT provided experts with deep knowledge of the vaccine market and its trends to address the project effectively. Our portfolio for this project included experts in the following roles: - Former Global President, Vaccines from a leading pharmaceutical company - Consultant - COVID Vaccines - Former VP US Marketing Lead, Vaccines from a leading pharmaceutical company

These experts provided a comprehensive view of the private-pay vaccine market, addressing key areas such as:

• Trends in vaccine usage post-COVID
• Private-pay vaccines (e.g., travel, influenza)
• Emerging vaccines and market trends
• Market growth drivers
• Future vaccine pipeline and popularity

BTHT actively scheduled and participated in the consultation in order to ensure smooth communication between the client and the experts.

OUTCOME

BTHT's experts offered valuable insights into the private-pay vaccine market in the US. By leveraging expert opinions, we identified key trends, growth drivers, and upcoming developments in the vaccine sector. This information enabled the client to understand market dynamics, consumer behavior, and future opportunities, assisting them in making informed decisions and strategizing effectively for the evolving vaccine landscape.